Colestipol

This classification denotes an anti-lipidemic agent with the molecular formula ((C3H5ClO)mon(C4H13N3)mon)co, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K50N755924, chemically known as 1,2-ethanediamine, n-(2-aminoethyl)-n-(2-((2-aminoethyl)amino)ethyl)-, polymer with (chloromethyl)oxirane but generally known as colestipol, which bears US NIH Compound Identifier 62816. European Medicines Agency schedules Colestipol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01425MIG. The term COLESTIPOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules colestipol in its Anatomical Therapeutic Chemical (ATC) Classification. COLESTIPOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule colestipol under HS 39140000 and SITC 57597. As of Q4 2014, COLESTIPOL remains the US FDA Preferred Term for this commodity. Colestipol bears US NLM identifiers UMLS ID C0009279 and NCI Concept Code C81540. SMILES: C1C(O1)CCl.C(CNCCNCCNCCN)N.